BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 257 filers reported holding BALCHEM CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,267,602 | +25.1% | 10,216 | +35.9% | 0.00% | 0.0% |
| Q2 2023 | $1,012,981 | +5.6% | 7,515 | -0.9% | 0.00% | 0.0% |
| Q1 2023 | $959,067 | +3.2% | 7,583 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $928,884 | +7.8% | 7,607 | +7.1% | 0.00% | 0.0% |
| Q3 2022 | $862,000 | +24.7% | 7,100 | +33.4% | 0.00% | 0.0% |
| Q2 2022 | $691,000 | +1.2% | 5,324 | +6.5% | 0.00% | +100.0% |
| Q1 2022 | $683,000 | -23.0% | 4,999 | -5.0% | 0.00% | -50.0% |
| Q4 2021 | $887,000 | +20.7% | 5,264 | +4.2% | 0.00% | 0.0% |
| Q3 2021 | $735,000 | +22.3% | 5,053 | +10.3% | 0.00% | +100.0% |
| Q2 2021 | $601,000 | +18.8% | 4,582 | +13.9% | 0.00% | 0.0% |
| Q1 2021 | $506,000 | +1.0% | 4,023 | -7.6% | 0.00% | 0.0% |
| Q4 2020 | $501,000 | +3.9% | 4,352 | -11.7% | 0.00% | 0.0% |
| Q3 2020 | $482,000 | +5.2% | 4,929 | +2.3% | 0.00% | -50.0% |
| Q2 2020 | $458,000 | -20.2% | 4,816 | -17.7% | 0.00% | 0.0% |
| Q1 2020 | $574,000 | – | 5,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANTA MONICA PARTNERS LP | 425,686 | $49,048,000 | 36.25% |
| Conestoga Capital Advisors, LLC | 939,134 | $108,207,000 | 1.72% |
| Tributary Capital Management, LLC | 197,207 | $22,722,000 | 1.63% |
| Ellsworth Advisors, LLC | 16,335 | $1,882,000 | 1.36% |
| GENEVA CAPITAL MANAGEMENT LLC | 693,677 | $79,926,000 | 1.35% |
| Brown Capital Management | 1,391,418 | $160,319,000 | 1.11% |
| BARD ASSOCIATES INC | 107,550 | $12,390,000 | 0.98% |
| Advantage Alpha Capital Partners LP | 38,370 | $4,421,000 | 0.97% |
| MOODY ALDRICH PARTNERS LLC | 50,270 | $5,792,000 | 0.94% |
| Cutter & CO Brokerage, Inc. | 29,369 | $3,384,000 | 0.89% |